Detalles de la búsqueda
1.
Osilodrostat, a potent oral 11ß-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's disease.
Pituitary
; 19(2): 138-48, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26542280
2.
A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use.
Hum Psychopharmacol
; 26(3): 224-36, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21671456
Resultados
1 -
2
de 2
1
Próxima >
>>